Dramatic Response to Crizotinib in an ALK-Positive Adenocarcinoma Patient with Disseminated Intravascular Coagulation
- 1 November 2013
- journal article
- case report
- Published by Elsevier BV in Journal of Thoracic Oncology
- Vol. 8 (11), e96-e98
- https://doi.org/10.1097/jto.0b013e3182a008ed
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Rapid Response of Brain Metastasis to Crizotinib in a Patient with ALK Rearrangement–Positive Non–Small-Cell Lung CancerJournal of Thoracic Oncology, 2013
- Successful Treatment with Crizotinib in Mechanically Ventilated Patients with ALK Positive Non–Small-Cell Lung CancerJournal of Thoracic Oncology, 2013
- Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 studyThe Lancet Oncology, 2012
- RET, ROS1 and ALK fusions in lung cancerNature Medicine, 2012
- Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancerNature, 2007